US1598641074
US1598641074
Charles River Laboratories Inte
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 14.41B EUR | 10.82B EUR | 8.31B EUR | 9.82B EUR |
Enterprise Value | 17.12B EUR | 13.66B EUR | 11.17B EUR | 12.17B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 23.62x | -- | -- | -- |
Price to Sales | 3.6x | 2.71x | 2.06x | 3.24x |
Price to Book | 5.07x | 3.81x | 2.83x | 3.1x |
EV/Revenue | 4.28x | 3.42x | 2.77x | 4.02x |
EV/EBITDA | 20.16x | 61.96x | 38.45x | 53.72x |
Price to FCF (P/FCF) | 30.73x | 29.21x | 21.23x | 24.17x |
EV/FCF | 36.51x | 36.86x | 28.55x | 29.98x |
FCF Yield | 3.25% | 3.42% | 4.71% | 4.14% |